Evaluation of Adherence to World Health Organization Guidelines on Clinical Management of Cryptococcal Meningitis among Health Care Providers in Selected Hospitals, Kisumu, Kenya
DOI:
https://doi.org/10.47604/gjhs.3281Keywords:
Cryptococcal Meningitis, Guidelines, Adherence, Health Care ProvidersAbstract
Purpose: Prevalence of Cryptococcal meningitis has risen and remained high over the last several decades in line with the HIV/ADS pandemic which has consequently led to the increase of Cryptococcal Meningitis associated mortality rates ranging from 17% to 100% in Africa. The aim of the present study was to assess the adherence to WHO guidelines on clinical management of CM in adults among HCP in JOOTRH and KCRH.
Methodology: This was a cross-sectional analytical study which was carried out in Kisumu County, Kenya. Sample size was obtained using Yamane (1967) formula. The sample calculation yielded a sample size of 119 respondents with a 97% response rate. Bivariate analysis was done using logistic regression from which chi square, odds ratios and the p- values were drawn
Findings: Findings from demographics showed that many were females (n=64, 55.2 %). Distribution of age bracket showed that many (n=74, 64.3%) were aged 30 years or below. From the results,76%(n=88) reported using lumbar puncture with rapid CrAg assay while very few reported using lumbar puncture with rapid cerebral spinal fluid India ink test (3%, n=4) in diagnosing cryptococcal meningitis. Majority (90.5%, n=105) reported using amphotericin B deoxycholate + fluconazole as first line antifungal therapy. In management of hypokalemia, majority (93%, n=56) did not monitor potassium daily but all (100%, n=60) administered 1 liter of normal saline infused with 20 mEq of potassium chloride two hours prior to each infusion of amphotericin B. 93%(n=56) did not administer two of 250-mg tablets of magnesium trisilicate, or magnesium chloride 4 mEq twice/ day for supplementation of magnesium.
Unique Contribution to Theory, Practice and Policy: This study recommends that the County government of Kisumu in collaboration with the two hospital management teams, need to organize and provide periodic training opportunities for the health care providers on the WHO guidelines on management of Cryptococcal meningitis whose prevalence is high in this region, and consistently avail current recommended clinical guideline/protocols in all the clinical departments to ease reference, hence promote adherence. In addition, they should include the aspect of adherence to WHO guidelines on management of cryptococcal meningitis, as one of the yearly appraisal objectives and provide timely supportive supervision in order to promote and streamline optimal adherence.
Downloads
References
Adeyemi, B.O., &Ross, A. (2014). Management of cryptococcal meningitis in a district hospital in Kwazuru-Natal: A clinical Audit. Afr j prm Health care fam Med.2014; 6(1), Art.//672,6 pages.
Babbie, E. (2004). The practice of social research (10th Ed); Thomson Belmont CA: Wadsworth Publishing Company.
Ganiem, A.R., Indrati, A.R., Wisaksana, R., Meijerink, H., &Van der Ven A. (2014). Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia. J Int AIDS Soc 17: 18821.
Govender, N.P, Meintjes, G., Bicanic, T., Dawood, H., Harrison, T.S., Jarvis, J.N. (2013). Guideline for the prevention, diagnosis and management of cryptococcal meningitis among HIV-infected persons: 2013 update by the Southern African HIV Clinicians Society. S Afr J HIV Med.; 14(2):76±86.
Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children, March 2018. Geneva: World Health Organization. License: CC BY-NC-SA 3.0 IGO.
Kothari, C. R. (2007). Research Methodology: Methods and Techniques. New Delhi: New Age International Publishers
Mdodo, R., Moser, S.A., Jaoko, W., Baddley, J., Pappas, P., Kempf, M.C. (2011). Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya. Mycoses; 54(5): e438–42.
Mugenda & Mugenda (2003), Research Methods: Quantitative and Qualitative Approaches
Oyella (2012): Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV infected adults in Uganda: a cross-sectional study. Journal of the International AIDS Society; 15:15.
Perfect, J.R., Dismukes, W.E, Dromer, F., Goldman, D.L., Graybill, J.R., Hamill, R.J. (2010). Clinical practice guidelines for the management of cryptococcal disease: update by the infectious diseases society of America. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America.; 50(3):291–322.
Rothe, C., Sloan, D.J., Goodson, P., Chikafa, J., &Mukaka, M, (2013). A Prospective Longitudinal Study of the Clinical Outcomes from Cryptococcal Meningitis following Treatment Induction with 800 mg Oral Fluconazole in Blantyre, Malawi. PLoS ONE 8(6): e67311.doi: 10.1371/journal.pone.0067311.
Sawadogo, S., Makumbi, B., Purfield, A., Ndjavera, C., Mutandi, G., &Maher, A. (2016). Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment. PLoS ONE 11(10): e0161830. doi: 10.1371/journal.pone.0161830.
Sidorenkov, G., Haaijer-Ruskamp, F.M, de Zeeuw, D., &Denig P. (2011). A Longitudinal Study Examining Adherence to Guidelines in Diabetes Care According to Different Definitions of Adequacy and Timeliness. PLoS ONE 6(9): e24278.doi: 10.1371/journal.pone.0024278.
Sloan, D.J, &Parris, V. (2014). Cryptococcal meningitis: Epidemiology and therapeutic options. Clin Epidemiol 6: 169-182.
World Health Organization (2011). Rapid Advice- Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-infected Adults, Adolescents and Children. Geneva: World Health Organization.
Yamane, T. (1967): Statistics: An Introductory Analysis, 2nd Ed., New York: Harper and Row.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Robina Ogendo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
